IP Verse

Fluticasone Furoate In The Treatment Of Copd - EP3650019

PATENT ANALYSIS

Patent Details

Grant Date
Oct 11, 2023
Company
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Oppositions

GENERICS [UK] LIMITED

SANDOZ AG

TEVA UK LIMITED

More patents of Glaxosmithkline Intellectual Property Development Limited

EP3650019

EP3297605

EP3461474

Want to monitor this patent?

Feel free to send us a message here and we will get back to you